Dr. Barnard earned her ScD in Epidemiology from the Harvard T.H. Chan School of Public Health. The primary goal of Mollie’s research is to use molecular epidemiology to inform ovarian cancer prevention and early detection strategies. Mollie was awarded a National Cancer Institute F99 Predoctoral to Postdoctoral Fellow Transition Award to study the role of inflammation and immunity in ovarian tumor development. For the K00 postdoctoral phase of this award, she worked with Dr. Jennifer Doherty at the Huntsman Cancer Institute (HCI) where she is researching the genetic epidemiology of ovarian cancer histotypes. Mollie collaborated with investigators from the Utah Population Database, the Utah Cancer Registry, and Intermountain Healthcare to study ovarian cancer high-risk pedigrees. She works on developing studies to discover susceptibility variants for ovarian cancer histotypes, and to describe the occurrence of other disease types in families at high risk of ovarian cancer.